chr13-36867271-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PVS1_ModeratePP5BS1_SupportingBS2_Supporting
The NM_001127217.3(SMAD9):c.781+2T>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,524,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001127217.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMAD9 | ENST00000379826.5 | c.781+2T>A | splice_donor_variant, intron_variant | Intron 4 of 6 | 5 | NM_001127217.3 | ENSP00000369154.4 | |||
SMAD9 | ENST00000350148.10 | c.671-1513T>A | intron_variant | Intron 3 of 5 | 1 | ENSP00000239885.6 | ||||
SMAD9 | ENST00000399275.7 | n.*381-1513T>A | intron_variant | Intron 3 of 5 | 1 | ENSP00000382216.3 | ||||
SMAD9 | ENST00000715264.1 | c.781+2T>A | splice_donor_variant, intron_variant | Intron 4 of 6 | ENSP00000520435.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152114Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000767 AC: 12AN: 156480 AF XY: 0.000121 show subpopulations
GnomAD4 exome AF: 0.000191 AC: 262AN: 1372616Hom.: 0 Cov.: 25 AF XY: 0.000187 AC XY: 127AN XY: 678618 show subpopulations
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74298 show subpopulations
ClinVar
Submissions by phenotype
Pulmonary hypertension, primary, 2 Pathogenic:2
This sequence change affects a donor splice site in intron 4 of the SMAD9 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SMAD9 are known to be pathogenic (PMID: 19419974, 31727138). This variant is present in population databases (rs770716081, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SMAD9-related conditions. ClinVar contains an entry for this variant (Variation ID: 541761). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
not provided Uncertain:1
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Identified in a patient with hypoplastic left heart syndrome, however, this patient also harbors variants in other genes (PMID: 28530678); This variant is associated with the following publications: (PMID: 28530678) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at